Yes, this is the most common and clinically appropriate solution
From 1987 to 1992, significant progress was made in cloning and characterizing the intestinal and renal SGLTs, leading to the development of selective SGLTis, known as gliflozins
The process by which the liver converts excess carbohydrates into triglycerides
Achieving these stringent endpoints, as outlined in the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE-II) consensus ( Research into mucosal healing has highlighted pathways involving interleukin-20 (IL-20), claudin-2 (CLDN2), and notoginsenoside R1 (NGR1) ( Figure 1 illustrates the differences in immune cell distribution within the intestinal crypts under homeostatic conditions compared with the inflammatory microenvironments of CD and UC
Fat-dissolving is an inflammatory process it needs time to work & recover
Consider increasing blood glucose monitoring for 1-2 weeks after stopping, as some patients may experience changes in blood sugar levels, making medical supervision during any treatment changes essential for your safety and continued health management